Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | FDC FDC Limited Pharma · Small | INNOVACAP Innova Captab Limited Pharma · Small | BLISSGVS Bliss GVS Pharma Limited Pharma · Small | NOVARTIND Novartis India Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 39 | 48 | 45 | 45 |
| Verdict | WATCHLIST | FAIR VALUE | WATCHLIST | WATCHLIST |
| Style | WATCHLIST | Financial Turnaround | Financial Turnaround | Financial Turnaround |
| Piotroski | 8/9 | 8/9 | 8/9 | 7/9 |
| Valuation | 5/30 | 5/30 | 6/30 | 5/30 |
| Growth | 8/25 | 17/25 | 13/25 | 15/25 |
| Quality | 2/20 | 8/20 | 4/20 | 2/20 |
| Balance Sheet | 14/15 | 9/15 | 10/15 | 13/15 |
| Cash Flow | 5/10 | 4/10 | 8/10 | 5/10 |
| Price | ₹394 | ₹914.7 | ₹421.6 | ₹1,331.4 |
| P/E | 21.60 | 37.40 | 34.00 | 36.90 |
| P/B | 2.58 | 4.79 | 3.72 | 4.20 |
| ROE | 12.50% | 13.70% | 11.60% | 11.60% |
| ROCE | 16.70% | 15.00% | 16.80% | 16.20% |
| Debt / Equity | 0.01 | 0.32 | 0.02 | 0.00 |
| FCF Yield | 1.40% | 0.19% | 2.28% | 1.89% |
| Dividend Y | 1.27% | 0.22% | 0.12% | 1.80% |
| Altman Z | 8.63 | 6.56 | 8.38 | 8.13 |
| Promoter % | 69.65% | 50.90% | 35.36% | 70.68% |
| Mkt Cap (₹Cr) | 6410.00 | 5250.00 | 4439.00 | 3435.00 |
| Graham # | ₹243.97 | ₹325.34 | ₹176.19 | ₹530.16 |
| Fair PE | 8.7 | 42.0 | 42.0 | 42.0 |
| MoS % | -161.7% | +11.6% | +17.8% | +16.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startFDC76
INNOVACAP96
BLISSGVS339
NOVARTIND138